Avalo Therapeutics (C6K0.STU) Q3 2026 Earnings

30JulConfirmed
Q2 2026
Next
-0.88
-0.76
-0.65
-0.54

Details

Expected EPS
-0.5392608
Actual EPS
N/A
Surprise EPS
0.54
Surprise Percent
+100%

Description

Avalo Therapeutics (C6K0.STU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts